Pages that link to "Q47398372"

The following pages link to Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs (Q47398372):

Displaying 40 items.

• Sympathetic nervous system overactivity and its role in the development of cardiovascular disease (Q28279754) (← links)
• (Q28372748) (← links)
• Selective activation of E-type prostanoid(3)-receptors reduces myocardial infarct size. A novel insight into the cardioprotective effects of prostaglandins (Q33989714) (← links)
• Therapeutic potential of ischaemic preconditioning (Q33994323) (← links)
• The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins. (Q34126239) (← links)
• Preconditioning of the response to ischemia/ reperfusion-induced plasma leakage in hamster cheek pouch microcirculation. (Q34403205) (← links)
• B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects (Q35027769) (← links)
• The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin (Q35041955) (← links)
• The impact of dose of the angiotensin-receptor blocker valsartan on the post-myocardial infarction ventricular remodeling: study protocol for a randomized controlled trial. (Q35639351) (← links)
• The kallikrein-kinin system as a regulator of cardiovascular and renal function (Q36389061) (← links)
• Beneficial Effects of Bradykinin on Myocardial Energy Metabolism and Infarct Size (Q36882195) (← links)
• Angiotensin II effects on ischemic focal ventricular tachycardia are predominantly mediated through myocardial AT(2) receptor (Q37174932) (← links)
• Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces (Q37369862) (← links)
• Review: AT 1-receptor blockade in experimental myocardial ischaemia/reperfusion (Q39092008) (← links)
• Bradykinin as an endogenous myocardial protective substance with particular reference to ischemic preconditioning--a brief review of the evidence (Q41143385) (← links)
• Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery (Q41788306) (← links)
• Differential presynaptic modulation of noradrenaline release in human atrial tissue in normoxia and anoxia (Q41788939) (← links)
• Stimulation of phosphatidylinositol hydrolysis, protein kinase C translocation, and mitogen-activated protein kinase activity by bradykinin in rat ventricular myocytes: dissociation from the hypertrophic response (Q42982748) (← links)
• Interaction between paracrine tumor necrosis factor-alpha and paracrine angiotensin II during myocardial ischemia. (Q43518237) (← links)
• Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium (Q43636305) (← links)
• Angiotensin II activates NADPH oxidase in isolated rat hearts subjected to ischaemia-reperfusion. (Q44318888) (← links)
• Enhancement of Left Ventricular Relaxation in the Isolated Heart by an Angiotensin-Converting Enzyme Inhibitor (Q46574454) (← links)
• Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs (Q47276862) (← links)
• Metabolism of bradykinin by the rat coronary vascular bed. (Q47767180) (← links)
• Purification and characterization of a kinin- and angiotensin II-forming enzyme in the dog heart (Q50528204) (← links)
• Participation of angiotensin II and bradykinin in contractile function in dog stunned myocardium (Q51433901) (← links)
• Renin inhibitors (Q70942045) (← links)
• Tissue angiotensin I-converting enzyme activity in ageing hamsters with and without cardiomyopathy (Q71834081) (← links)
• Role of Bradykinin in Protection of Ischemic Preconditioning in Rabbit Hearts (Q71974392) (← links)
• Effects of the insurmountable angiotensin AT1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts (Q73064446) (← links)
• Angiotensin II receptor blockade and myocardial fibrosis of the infarcted rat heart (Q73227389) (← links)
• Angiotensin and bradykinin peptides in rats with myocardial infarction (Q73246467) (← links)
• Role of cardiac renin-angiotensin system in sarcoplasmic reticulum function and gene expression in the ischemic-reperfused heart (Q73274267) (← links)
• Structure of a kallikrein-like enzyme and its tissue localization in the dog (Q73288480) (← links)
• Angiotensin-converting enzyme inhibitors potentiate preconditioning through bradykinin B2 receptor activation in human heart (Q73407536) (← links)
• Effect of bradykinin B2-receptor antagonism on post-ischemic coronary reperfusion (Q73521978) (← links)
• Force-length relationship in dogs as a measure of protective effect of imidapril on regional myocardial ischemia and reperfusion injury (Q73525818) (← links)
• Are the Inotropic and Antiarrhythmic Effects of Bradykinin Due to Increases in Coronary Flow? (Q73689581) (← links)
• Streptokinase, complement activation and hypotension (Q73699747) (← links)
• Unchanged cardiac angiotensin II levels accompany losartan-sensitive cardiac injury due to nitric oxide synthase inhibition (Q74317109) (← links)